Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Nexstim Plc Updates Its Corporate Strategy

Read more ››
By: GlobenewsWire - 13 Aug 2020

PDS Biotechnology Reports Financial Results for the Second Quarter 2020 and Provides Business Update

Read more ››
By: GlobenewsWire - 13 Aug 2020
Related companies:  PDS Biotechnology Corporation

Digirad Corporation Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2020

Read more ››
By: GlobenewsWire - 13 Aug 2020
Related companies:  Digirad Corporation

RedHill Biopharma and Cosmo Pharmaceuticals to Expand Strategic Partnership with Exclusive Licensing Agreement and Manufacturing Agreement for Multiple Products

Read more ››
By: GlobenewsWire - 13 Aug 2020
Related companies:  RedHill Biopharma Ltd.

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results

Read more ››
By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  WuXi AppTec, Inc. | WuXi AppTec Inc. | WuXi AppTec Advanced Therapies | WuXi AppTec

Photocure appoints Genotests as exclusive partner for Hexvix in Chile

OSLO, Norway, Aug. 13, 2020 /PRNewswire/ -- Photocure ASA (OSE: PHO), today announced the appointment of Genotests SpA as the exclusive distributor for the commercialization of Hexvix(®) in Chile.

Read more ››
By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Photocure ASA

Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA

STOCKHOLM, Aug. 13, 2020 /PRNewswire/ -- Transaction adds late-stage orphan pipeline asset and platform in inflammation and fibrosis. Calliditas to acquire 62.7% of Genkyotex for EUR20.3M in cash at EUR2.80 per share in an off-market transaction. Following the closing of the control transaction... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Calliditas Therapeutics AB

Calliditas Therapeutics: Interim Report Q2, 2020

Successful capital raise on NASDAQ

Read more ››
By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Calliditas Therapeutics AB

Invitation to presentation of Immunovia's interim report January - June 2020 on August 20, 2020

LUND, Sweden, Aug. 13, 2020 /PRNewswire/ -- Immunovia invites to a teleconference (in English) for investors, analysts and media on Thursday, August 20(th), 2020 at 16:30 CET. Immunovia will publish the company's interim report on August 20(th), 2020 at 16:00 CET.

Read more ››
By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Immunovia AB

Isofol enters licensing agreement with Solasia to develop and commercialize arfolitixorin in Japan

GOTHENBURG, Sweden, Aug. 13, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) today announced that it entered into a license agreement with Solasia Pharma K.K ("Solasia") (TSE: 4597), a specialized oncology company headquartered... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Isofol Medical AB

Invitation to a conference call and webcast by Isofol in connection with the entered license agreement with Solasia

GOTHENBURG, Sweden, Aug. 13, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced that it entered into a license agreement with Solasia Pharma K.K ("Solasia") (TSE: 4597), to develop and commercialize Isofol's proprietary... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Isofol Medical AB

Eggshell-based surgical material for skull injuries

MOSCOW, Aug. 13, 2020 /PRNewswire/ -- A bioactive polymer-ceramic composite for fixing implants and restoring bone defects in the skull was developed by an international group of materials scientists from the NUST MISIS Center for Composite Materials. An innovative composition of the material... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020

Sosei Heptares Operational Highlights and Consolidated Results for the First Half 2020

TOKYO and LONDON, Aug. 13, 2020 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) provides an update on operational activities and reports its consolidated results for the first half ended 30 June 2020. The full report can be accessed by Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020

THREAD Accelerates Expansion to Advance Global Decentralized Clinical Trials

DURHAM, N.C., Aug. 13, 2020 /PRNewswire/ -- THREAD, an innovative technology and service provider that enables decentralized clinical... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Jones Lang LaSalle Incorporated (JLL) | Water Street Healthcare Partners, LLC | Jones Lang LaSalle (JLL)

NTN Buzztime, Inc. and Brooklyn ImmunoTherapeutics LLC Enter into Definitive Merger Agreement

CARLSBAD, Calif. and BROOKLYN, N.Y., Aug. 13, 2020 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) and Brooklyn ImmunoTherapeutics LLC ("Brooklyn"), a privately-held biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020
Related companies:  Brooklyn ImmunoTherapeutics

Adverum Biotechnologies Announces Pricing of Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 13 Aug 2020
Related companies:  Adverum Biotechnologies, Inc.

Daridorexant Phase 3 results in insomnia to be presented at SLEEP 2020

Read more ››
By: GlobenewsWire - 13 Aug 2020
Related companies:  Idorsia Pharmaceuticals Ltd

Bone Therapeutics receives EUR 1.0 million to advance ongoing JTA-004 phase III knee osteoarthritis study

Read more ››
By: GlobenewsWire - 13 Aug 2020
Related companies:  Bone Therapeutics SA

CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company

SHANGHAI, Aug. 13, 2020 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SHSE: 688185, HKEX:06185) announced today that it has successfully listed on the Sci-Tech Innovation Board (STAR Market) of the Shanghai Stock Exchange, making it the first "A+ H" dual listing vaccine company. CanSinoBIO... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020

QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma

BRISBANE, Australia, Aug. 12, 2020 /PRNewswire/ -- QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, is pleased to announce that it has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA),... Read more ››

By: PR Newswire Association LLC. - 13 Aug 2020
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑